Domů › CHOPN › Alabama › Birmingham
Klinické studie CHOPN v Birmingham, AL
17 studií pro CHOPN hledá účastníky v lokalitách v Birmingham a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Probíhá náborFáze 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Probíhá náborFáze 2
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Probíhá náborFáze 4
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Probíhá náborFáze 2
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Probíhá náborFáze 2
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Probíhá náborFáze 1
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Probíhá náborFáze 2/3
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Probíhá náborFáze 3
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
Probíhá náborObservační studie
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
Probíhá náborFáze 3
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Probíhá nábor
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Probíhá nábor
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Probíhá nábor
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
Probíhá náborObservační studie
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Probíhá náborFáze 4
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Probíhá nábor
- UAB School of Medicine/Lung Health Center, Birmingham
Studie CHOPN v jiných městech
- Philadelphia, PA23 studií
- Miami, FL18 studií
- Boston, MA17 studií
- Houston, TX15 studií
- Orlando, FL15 studií
- Baltimore, MD14 studií
- Chicago, IL14 studií
- Dallas, TX12 studií
- Pittsburgh, PA12 studií
- New York City, NY11 studií
- Ann Arbor, MI10 studií
- Winston-Salem, NC9 studií
Další studie v Birmingham
- Rakovina (všechny typy)30 studií
- Rakovina prsu24 studií
- Obesity23 studií
- Rakovina vaječníků23 studií
- Nemalobuněčný plicní karcinom22 studií
- Akutní myeloidní leukemie21 studií
- Mnohočetný myelom18 studií
- Kardiovaskulární onemocnění17 studií
- Nadváha16 studií
- Rakovina endometria16 studií
- Diabetes mellitus 2. typu16 studií
- Cystická fibróza16 studií
Zdroj: ClinicalTrials.gov, data načtena 4. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.